A Study of RAY1225 in Participants With Obesity

NCT06254261 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: RAY1225
DRUG: Placebo

Sponsor

Guangdong Raynovent Biotech Co., Ltd